AxoGen Inc reports results for the quarter ended December 31 - Earnings Summary
25/02/2025 14:32
AxoGen Inc AXGN.OQ reported quarterly adjusted earnings of 7 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of six analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from -1 cents to 5 cents per share. Revenue rose 15.1% to $49.41 million from a year ago; analysts expected $48.57 million. AxoGen Inc's reported EPS for the quarter was 1 cent. The company reported quarterly net income of $450 thousand. AxoGen Inc shares had risen by 9.3% this quarter. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 33.3% in the last three months. In the last 30 days, there have been no negative revisions of earnings estimates RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" Wall Street's median 12-month price target for AxoGen Inc is $22.00 This summary was machine generated from LSEG data February 25 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | 0.03 | 0.07 | Beat |
| Sep. 30 2024 | 0.01 | 0.07 | Beat |
| Jun. 30 2024 | -0.04 | 0.05 | Beat |
| Mar. 31 2024 | -0.07 | -0.06 | Beat |